Nghia Nguyen, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 327 Beach 19th St, St John Episcopal Hospital, Far Rockaway, NY 11691 Phone: 718-869-7672 |
News Archive
Businesses are concerned that non-religious employers will end up covering the bill for religious groups that refuse to pay for contraception for their employees. Meanwhile, church leaders continue their push to broaden the exemption from the contraception coverage rule.
An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure, or the time it takes for previously treated cancer to return as indicated by prostate specific antigen rise, could be used as a surrogate endpoint for locally advanced prostate cancer.
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). An analysis of long-term efficacy data demonstrated that blinatumomab produced prolonged remissions in patients with ALL. As of November 2010, the hematologic disease free survival (DFS) was 60%, with a follow-up of up to 27.5 months.
The New York Times Prescriptions Blog: "The question of equality, or inequality, among states is a major reason President Obama's overhaul of the health care system, and the legislation in Congress to make it happen, seemed to reach the brink of collapse last week." The issue also reflects "one of the biggest challenges" the President and Congressional leaders face in their efforts to overhaul the health care system. The key question: "how to devise a national solution for a problem that varies sharply from state to state."
› Verified 8 days ago